Why Viking Therapeutics Stock Bumped 3% Higher Today
A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX) stock on Friday, which closed the trading session 3% higher. That figure was well higher than the 0.7% increase of the benchmark S 500 index.
That rival is Novo Nordisk, which announced that its current CEO Lars Jørgensen is to vacate his position.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Stock
€27.32
-0.290%
Currently there is a rather positive sentiment for Viking Therapeutics Inc with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 45 € shows a very positive potential of 64.71% compared to the current price of 27.32 € for Viking Therapeutics Inc.
